Paxil CR

GSK is a leading global biopharmaceutical company headquartered in London, United Kingdom, dedicated to uniting science, technology, and talent to get ahead of disease together. The company focuses on the research, development, and manufacturing of innovative vaccines and specialty medicines, with core therapeutic areas in infectious diseases, HIV, oncology, and immunology/respiratory. GSK maintains a dominant position in the global vaccines market and operates ViiV Healthcare, a specialist HIV company, in partnership with Pfizer and Shionogi. Formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, the company has a long history of developing blockbuster treatments, including the SSRI Paxil CR. GSK continues to invest heavily in advanced modalities such as mRNA and antibody-drug conjugates to address significant unmet medical needs.